Sanstar ₹198-crore Preferential Issue Approved in 2026

What shareholders approved at the June 20 EGM

Sanstar Limited shareholders approved a preferential issue of equity shares to Corn Products Development Inc., an Ingredion group company. The approval came at an Extraordinary General Meeting (EGM) held on June 20, 2026 through video conferencing (VC/OAVM). The company said the issue price is ₹110 per equity share, including a premium of ₹108. The allotment involves 1,80,24,157 equity shares, which is about 1.80 crore shares. Based on the disclosed numbers, the transaction aggregates to around ₹198.27 crore (also referenced as approximately ₹198.3 crore). Sanstar also stated that the investment will not result in any change in management or control.

Preferential allotment terms and post-issue stake

The preferential issue will result in Corn Products Development Inc. holding about 9% of Sanstar’s post-issue share capital. The investor is classified as a non-promoter category allottee in the disclosures around the EGM resolutions. Sanstar’s board had approved the proposal earlier on May 28, 2026. The company has also indicated it received in-principle approval from BSE and NSE for the preferential issue. The allotment is part of a broader strategic partnership between Sanstar and Ingredion, alongside plans to establish a jointly-owned venture in India.

Use of proceeds: working capital and general corporate purposes

Mr. Sambhav Gautam Chowdhary, Joint Managing Director, told members that the proceeds are intended primarily for working capital requirements and general corporate purposes. The company has also indicated deployment is expected in FY 2026-27. In a separate disclosure related to the EGM notice, Sanstar said Acuité Ratings & Research Limited has been appointed as the monitoring agency. The stated purpose is to track utilisation of proceeds consistent with the fund-raise objectives.

Governance and special rights granted to the investor

Alongside the share issuance, shareholders approved granting special rights to the proposed allottee. These include the right to nominate an “Investor Director” to Sanstar’s board. The rights also include pre-emptive rights on future equity issuances. Sanstar also disclosed consultation or affirmative voting rights on certain key corporate matters. These rights were approved in line with Regulation 31B of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as stated by the company.

Five resolutions passed, including capital clause changes

Sanstar said shareholders approved five special business items at the EGM. These included increasing the authorised share capital and altering the capital clause of the Memorandum of Association. Amendments to the Memorandum of Association (MOA) and Articles of Association were also approved to align the company’s constitutional documents with the agreed arrangements. The company has framed these steps as necessary to formalise the preferential allotment and the related governance covenants.

Regulatory and procedural steps still pending

Even after shareholder approval, the company must complete specific regulatory and procedural conditions. Sanstar indicated it needs to file a listing application within 20 days of allotment. It also cited the requirement to obtain necessary statutory approvals, including from SEBI, RBI, and the Ministry of Corporate Affairs (MCA), where applicable. These steps are part of the typical post-approval workflow for a preferential allotment and subsequent listing of the newly issued shares.

Timeline: board approval, e-voting, and the EGM

Sanstar had republished a newspaper advertisement regarding the EGM and the VC/OAVM process. The EGM was scheduled for June 20, 2026 at 11:00 a.m. IST. The company also disclosed that remote e-voting would commence on June 17, 2026 at 9:00 a.m. IST. These details helped set the process for shareholder participation and final approval of the resolutions.

Key numbers at a glance

The disclosed numbers across filings and updates point to a consistent structure: 1.80 crore shares at ₹110 per share for roughly ₹198.27 crore, translating into about a 9% post-issue holding for the investor. Sanstar has also highlighted that the transaction does not change management control. The authorised share capital increase disclosed by the company is from ₹38 crore to ₹50 crore, subject to the approvals already taken through the shareholder route.

Wider partnership context: joint venture plans

Separately, the disclosed partnership framework includes forming a joint venture with Ingredion India and Amishi Drugs for specialty ingredients. Sanstar has also referred to a jointly-owned venture in India aimed at specialty pharmaceutical excipients and other high-value ingredient solutions. The partnership includes a definitive shareholders’ agreement to set up a JV entity focused on manufacture, sale, and distribution of specialty pharmaceutical and other specialty ingredient products in India. The disclosures also refer to a plan to set up a manufacturing facility in western India.

Market snapshot mentioned in the update

A market data snapshot included alongside the news indicated Sanstar’s share price at ₹116.45, up ₹1.33 (1.16%) for the day. The update was timestamped “Last updated on 19 Jun, 2026 | 15:54 IST.” While the preferential issue price is ₹110 per share, the market price reference provides context on where the stock was trading shortly before the EGM date.

Why the approval matters for investors

The EGM approval clears the core shareholder step for Sanstar’s ₹198.27 crore capital raise and formalises investor governance rights tied to the transaction. It also aligns Sanstar’s corporate documents and share capital structure with the proposed allotment and associated agreements. At the same time, the company has clearly listed further compliance requirements, including listing filings and statutory approvals. The next milestones will be the completion of these conditions and the allotment process, followed by the required listing application within the stated timeline.